R Retreatment in 1st Relapsed DLBCL

Summary

It is a phase II , multicenter, open label clinical trial. Only the relapsed DLBCL patients after 1st line induction treatment of 6\~8 cycles of RCHOP-like chemo will be enrolled to receive 3 cycles of RICE as salvage therapy. After treatment each patient should be followed up for 2 years.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications